A Study to Evaluate Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Aged 3 Through 5 Years Who Have a Specified CFTR Gating Mutation
Clinical trial NCT02742519 · TERMINATED
Trial details
- NCT number
- NCT02742519
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.